P Hubert
Université de Liège
H-index: 38
Europe-Belgium
Top articles of P Hubert
Exploring the impact of methylglyoxal stress on tumor immunity
2024/2/6
Methylglyoxal stress: a novel role in tumor immunity?
2023/10/27
Enhancement of anti-tumor immunity through interference with glycation stress in breast cancer
2023
Human papillomavirus E6/E7 oncoproteins promote radiotherapy-mediated tumor suppression by globally hijacking host DNA damage repair
Theranostics
2023
Caractérisations histopathologiques des cancers œsophagiennes et potentiel implication des infections par HPV de haut-risques
2022/9/29
Histopathological characterization of esophageal tumors and potential involvement of high-risk HPV in carcinogenesis
2022/9/9
Methylglyoxal reshapes breast tumor immune microenvironment
2022/6/21
HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources
Nature Communications
2022/2/28
Immunosuppressive effect of methylglyoxal stress in breast cancer
2022
Methylglyoxal regulates the recruitment of tumor-infiltrating immunosuppressive cells in breast cancer
2022
Histopathological characterization of esophageal cancers and potential role of high-risk HPV infections
2021/12/14
Caractérisation histopathologique des cancers œsophagiens et potentiel rôle des HPV
2021/10/1
Cancer immunotherapy: it’s time to better predict patients’ response
2021/9/28
Methylglyoxal, a byproduct of glycolysis, modulates breast cancer immune landscape
2021
Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy
Journal for immunotherapy of cancer
2021
Treatment algorithm and prognostic factors for patients with stage I–III carcinoma of the anal canal: a 20-year multicenter study
Modern Pathology
2021/1
Pyruvate dehydrogenase kinase/lactate axis: A therapeutic target for neovascular age-related macular degeneration identified by metabolomics
Journal of Molecular Medicine
2020/12
P08. 03 Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy
2020/10/1
TGFα promotes chemoresistance of malignant pleural mesothelioma
Cancers
2020/6/6